Skip to main content

Table 1 Clinical characteristics of the study subjects

From: Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses

No. Age FIGO stage Histotype GradeA Regimen after primary surgery Evaluation
1 61 III Serous III Paclitaxel/ Oxaliplatin Sensitive
2 44 III Serous II Paclitaxel/Nedaplatin Sensitive
3 60 II Endometrioid II Paclitaxel/Nedaplatin Sensitive
4 50 III Serous II Paclitaxel/Oxaliplatin Sensitive
5 55 III Serous II Paclitaxel/Oxaliplatin Sensitive
6 43 I clear cell carcinomas II Paclitaxel/Oxaliplatin Sensitive
7 51 III Serous II Paclitaxel/Oxaliplatin Sensitive
8 59 III Endometrioid II Paclitaxel/Oxaliplatin Sensitive
9 50 III Serous II Paclitaxel/Oxaliplatin Sensitive
10 55 II Serous III Paclitaxel/Oxaliplatin Sensitive
11 50 I Serous III Paclitaxel/Oxaliplatin Sensitive
12 56 III Serous III Paclitaxel/Oxaliplatin Sensitive
13 65 II Endometrioid III Paclitaxel/Nedaplatin Sensitive
14 58 II Serous III Paclitaxel/Oxaliplatin Sensitive
15 50 III Serous II Paclitaxel/Oxaliplatin Sensitive
16 59 III Endometrioid II Paclitaxel/Nedaplatin Sensitive
17 60 III Serous II Paclitaxel/Oxaliplatin Sensitive
18 63 III Serous II Paclitaxel/Oxaliplatin Sensitive
19 67 III Serous II Paclitaxel/Oxaliplatin Sensitive
20 58 III Serous II Paclitaxel/Oxaliplatin Sensitive
21 58 III Serous III Paclitaxel/Oxaliplatin Resistance
22 56 III Serous II Paclitaxel/Oxaliplatin Resistance
23 63 III Serous II Paclitaxel/Oxaliplatin Resistance
24 63 III Serous III Paclitaxel/Nedaplatin Resistance
25 68 IV Serous II Paclitaxel/ Carboplatin Resistance
26 50 III Serous III Paclitaxel/Oxaliplatin Resistance
27 48 III Serous III Paclitaxel / Carboplatin Resistance
28 49 III Serous III Paclitaxel/ Nedaplatin Resistance
29 63 IV Serous II Paclitaxel/ Nedaplatin Resistance
30 56 III Endometrioid III Paclitaxel/Oxaliplatin Resistance
31 61 IV Serous II Paclitaxel/Nedaplatin Resistance
32 40 II Serous II Paclitaxel/Nedaplatin Resistance
33 50 III Serous II Paclitaxel/Oxaliplatin Resistance
34 65 III Serous II Paclitaxel/Oxaliplatin Resistance
35 59 III Serous II Paclitaxel/Oxaliplatin Resistance
36 40 IV Serous II Paclitaxel/Oxaliplatin Resistance
37 62 III Serous II Paclitaxel/ Carboplatin Resistance
38 46 III Serous II Paclitaxel/Oxaliplatin Resistance
39 52 III Serous II Paclitaxel/Oxaliplatin Resistance
40 53 III Serous II Paclitaxel/Nedaplatin Resistance
  1. A is graded according to the degree of differentiation (I-low grade, II- middle grade, III- high grade)